Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
Condition: Multiple Sclerosis, Relapsing-Remitting Intervention: Drug: Natalizumab Injection [Tysabri] Sponsors: University Hospital, Caen; Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials